Bloomberg Markets with Carol Massar and Cory Johnson.\u0010\u0010GUEST:\u0010David Wilson\u0010Stocks Editor\u0010Bloomberg News\u0010Discussing his "Stock of the Day" Pulse Biosciences (PLSE). Pulse Biosciences Inc.'s shares plunged as much as 40 percent after the medical-device developer withdrew an application for U.S. approval of its first product. The company said it couldn't provide additional data requested by regulators within a 90-day review period, which ended yesterday. Pulse said it plans to reapply once the data has been generated.

USC's Jeffrey Cole and Harlan Lebo on Google, AI, and Disruptive Innovation
17:29

Trump Meets Xi in Washington as Domestic Woes Grow
35:17

Anthony Scaramucci on Trump, Wall Street and America’s Economic Anger
19:44